Skip to main content
Blood Advances logoLink to Blood Advances
. 2020 May 15;4(10):2135. doi: 10.1182/bloodadvances.2020002200

Ceriani L, Gritti G, Cascione L, et al. SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model. Blood Adv. 2020;4(6):1082-1092.

PMCID: PMC7252543  PMID: 32413128

In the legends to Figures 1 (page 1086) and 2 (page 1087), “PDF” should read “PFS.” The errors have been corrected in the published article.


Articles from Blood Advances are provided here courtesy of The American Society of Hematology

RESOURCES